Conversely, elevated Gal-3 levels, commonly observed in metabolic syndrome, obesity, and diabetes–frequent comorbidities in AMI patients–contribute to insulin resistance and impaired glucose metabolism. This evidence concerns the gene LGALS3 and Insulin resistance.